“At IPS, we’re proud to receive this award for our innovative medical device design of this revolutionary product,” said Bob Wild, CEO of Intelligent Product Solutions. “Working with Dominion ...
The allowance of all requested claims for the two components of the non-surgical FemBloc permanent birth control marks a key milestone in extending protection for this revolutionary alternative to ...
Logo Myocene MYOCENE kicks off the first FDA De Novo clearance of 2025 for its groundbreaking muscle fatigue monitoring device. LIèGE, ...